Name
pdei2
Label
Phosphodiesterase Inhibitors (SHHS2)
Description

Participant taking PHOSPHODIESTERASE INHIBITORS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
  • 8: Don't know
Type
choices
Phosphodiesterase Inhibitors (SHHS2) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,555 -
Yes - - 65 -
Don't know - - - -
Unknown - - 460 -
Phosphodiesterase Inhibitors (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 175 641 1,136 1,030 533 40 3,555
Yes 1 6 12 26 20 - 65
Don't know - - - - - - -
Unknown 8 60 173 144 71 4 460
Phosphodiesterase Inhibitors (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,635 1,920 3,555
Yes 26 39 65
Don't know - - -
Unknown 200 260 460
Phosphodiesterase Inhibitors (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,107 232 216 3,555
Yes 55 10 - 65
Don't know - - - -
Unknown 425 14 21 460